Features

Clinical evaluation of MiSight 1 day contact lens for myopia control: Three-year milestone results

With prevalence and progression of myopia increasing globally, and interest growing on myopia management in the UK, Paul Chamberlain, Kathy Dumbleton and Elizabeth Lumb summarise results from a recent peer-reviewed publication on the landmark three-year, randomised clinical trial of MiSight 1 day, the world’s first soft contact lens proven to slow the progression of myopia in children

The prevalence of myopia is increasing at an unprecedented rate worldwide with current estimates at 23% of the world’s population and a predicted increase to almost 50% by 2050.1 In the United Kingdom (UK) nearly one in five teenagers is myopic,2 and faster progression has been reported to occur in pre-teens.2-4 The debilitating consequences of myopia-associated pathology help to explain why it is not surprising that eye care professionals (ECPs) in the UK and around the world have become increasingly concerned for their young myopic patients, and are keen to discuss treatment options with their patients’ parents.5

Myopia Control with Contact Lenses

Register now to continue reading

Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.

Register

Already have an account? Sign in here